Frequently Asked Questions
The market is segmented based on , By Type (Primary, Secondary), Cause (Congenital Aphakia, Surgical Aphakia, Acquired Aphakia), Treatment (Spectacles, Contact Lenses, Intraocular Lens Implantation, Refractive Surgery, Others), End Users (Hospitals, Ophthalmic Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
.
The Global Aphakia Market size was valued at USD 0.00 USD Billion in 2021.
The Global Aphakia Market is projected to grow at a CAGR of 10.4% during the forecast period of 2022 to 2028.
The major players operating in the market include Johnson & Johnson Services , Ophtec BV, Novartis AG, Bausch Health, ZEISS International, Rayner Intraocular Lenses Limited, Aetna , CooperVision, Menicon Co. , Labtician Ophthalmics , Artificial Eye Co., Allergan, Abbott, UltraVision CLPL, Alcon , Bausch & Lomb ,orporated, ESSILOR VISION FOUNDATION AUSTRALIA PTY LIMITED, Contamac, SynergEyes, Solótica Indústria e Comércio Ltda, among others,.
